Page last updated: 2024-10-27

gentamicin and Dyslipidemias

gentamicin has been researched along with Dyslipidemias in 1 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hegazy, AM1
Abdel-Azeem, AS1
Zeidan, HM1
Ibrahim, KS1
Sayed, EE1

Other Studies

1 other study available for gentamicin and Dyslipidemias

ArticleYear
Hypolipidemic and hepatoprotective activities of rosemary and thyme in gentamicin-treated rats.
    Human & experimental toxicology, 2018, Volume: 37, Issue:4

    Topics: Animals; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury; Disease Models, Animal; D

2018